Scientists test safety of mixing new CF drugs with common meds
NCT ID NCT07349394
Summary
This early-stage study aims to understand how a new triple-drug combination for cystic fibrosis (VNZ/TEZ/D-IVA) affects the body's processing of a common cholesterol drug called rosuvastatin. It involves 18 healthy volunteers to check for any safety issues when these medications are taken together. The main goal is to gather data on drug interactions before testing in people with cystic fibrosis.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altasciences - Kansas City
Overland Park, Kansas, 66212, United States
Conditions
Explore the condition pages connected to this study.